Toyoshima T, Koch F, Kaemmerer P, Vairaktaris E, Al-Nawas B, Wagner W
Department of Oral and Maxillofacial Surgery, Johannes-Gutenberg University, Mainz, Germany.
J Oral Pathol Med. 2009 Jul;38(6):530-4. doi: 10.1111/j.1600-0714.2009.00748.x. Epub 2009 Feb 13.
BACKGROUND: The aim of this study was to determine the detection of cytokeratin (CK) mRNA in oral squamous cell carcinoma (OSCC) cells and to evaluate the CK relevance for OSCC diagnosis in a brush biopsy test. METHODS: Fifty-two pairs of OSCC cells and normal oral mucosal cells were obtained by brush biopsy from OSCC patients. mRNA was extracted from cell pellets for real-time quantitative reverse transcriptase polymerase chain reaction (RT-qPCR). The over-expression levels of CK 17, CK 19 and CK 20 mRNA in OSCC cells were examined by SYBR green real-time RT-qPCR. RESULTS: Compared to normal mucosal cells, the over-expression of CK 17 mRNA was detectable in 40 OSCC cells (76.9%), that of CK 19 mRNA in 19 (36.5%), while that of CK 20 mRNA was not detectable. Compared with CK 19, the mean value of CK 17 mRNA expression level was significantly higher in all 52 patients (P < 0.02). Moreover, the value of CK 17 was significantly higher in T1 and T2 OSCC patients (P < 0.03, respectively), in patients without metastases of neck lymph nodes (P < 0.04), in stage I and stage II patients (P < 0.03 and P < 0.05, respectively) and in well differentiated OSCC patients (P < 0.05). CONCLUSION: Brush biopsy properly serves for detection of CK mRNA using real-time RT-qPCR. This preliminary study demonstrates the CK 17 possibility for application; however, pivotal studies are encouraged to confirm CK 17 as a diagnostic marker of OSCC in a brush biopsy test.
背景:本研究旨在确定口腔鳞状细胞癌(OSCC)细胞中细胞角蛋白(CK)mRNA的检测情况,并在刷检活检试验中评估CK与OSCC诊断的相关性。 方法:通过对OSCC患者进行刷检活检,获取52对OSCC细胞和正常口腔黏膜细胞。从细胞沉淀中提取mRNA,用于实时定量逆转录聚合酶链反应(RT-qPCR)。采用SYBR Green实时RT-qPCR检测OSCC细胞中CK 17、CK 19和CK 20 mRNA的过表达水平。 结果:与正常黏膜细胞相比,40例OSCC细胞(76.9%)中可检测到CK 17 mRNA过表达,19例(36.5%)中可检测到CK 19 mRNA过表达,而未检测到CK 20 mRNA过表达。在所有52例患者中,CK 17 mRNA表达水平的平均值显著高于CK 19(P < 0.02)。此外,在T1和T2期OSCC患者中(分别为P < 0.03)、无颈部淋巴结转移的患者中(P < 0.04)、I期和II期患者中(分别为P < 0.03和P < 0.05)以及高分化OSCC患者中(P < 0.05),CK 17的值均显著更高。 结论:刷检活检适用于通过实时RT-qPCR检测CK mRNA。这项初步研究证明了CK 17具有应用可能性;然而,鼓励开展关键研究以在刷检活检试验中确认CK 17作为OSCC的诊断标志物。
J Cancer Res Clin Oncol. 2008-4
World J Methodol. 2016-3-26